Ultima Genomics
A new era of sequencing
Fremont, United States · Founded 2016 · $1.1B raised
- Headquarters
- Fremont, California
- Employees
- 201–500
- Founded
- 2016
- Business Model
- B2B
- Website
- ultimagenomics.com
- Total Funding
- $1.1B
- Last Round
- $95.0M Series EJun 2022
- Rounds
- 7
About
Ultima Genomics develops next-generation DNA sequencing platforms using semiconductor-based open wafer technology to dramatically reduce sequencing costs. Their UG100 and UG200 series can sequence over 60,000 whole genomes annually at costs below $1 per genome, enabling population-scale genomic research. The company leverages AWS GPU computing for ML-based basecalling and large-scale genomic data processing.
Summary
Ultima Genomics is an Artificial Intelligence company based in Fremont, United States, founded in 2016. It has raised $1.1B in total across 7 rounds, most recently a $95.0M Series E round in Jun 2022. Investors include General Atlantic, Andreessen Horowitz and Khosla Ventures.
Tech & App Stack
9 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2022
Sign up to see all 7 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company